<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-KVQ4ANZ4</identifier><date>2022</date><creator>Fürst, Jurij</creator><creator>Pestotnik, Anita</creator><creator>Povše Konda, Majda</creator><creator>Samaluk, Vita</creator><relation>documents/doc/K/URN_NBN_SI_doc-KVQ4ANZ4_001.pdf</relation><relation>documents/doc/K/URN_NBN_SI_doc-KVQ4ANZ4_001.txt</relation><format format_type="issue">4</format><format format_type="volume">73</format><format format_type="type">article</format><format format_type="extent">str. 293-300</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">139132675</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-KVQ4ANZ4</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">financiranje</subject><subject language_type_id="slv">javno zdravje</subject><subject language_type_id="slv">lista zdravil</subject><subject language_type_id="slv">magistralna zdravila</subject><subject language_type_id="slv">nadzori</subject><subject language_type_id="slv">obvezno zdravstveno zavarovanje</subject><title>Pogled Zavoda za zdravstveno zavarovanje Slovenije na področje magistralnih zdravil</title><title>View of the Health Insurance Institute of Slovenia on the field of extemporaneously prepared medicines</title></Record>